329 related articles for article (PubMed ID: 26227068)
1. Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication.
Wallach-Kildemoes H; Hansen EH
Eur J Clin Pharmacol; 2015 Oct; 71(10):1245-54. PubMed ID: 26227068
[TBL] [Abstract][Full Text] [Related]
2. Variability of the LDL-C lowering response to ezetimibe and ezetimibe + statin therapy in hypercholesterolemic patients.
Descamps O; Tomassini JE; Lin J; Polis AB; Shah A; Brudi P; Hanson ME; Tershakovec AM
Atherosclerosis; 2015 Jun; 240(2):482-9. PubMed ID: 25913444
[TBL] [Abstract][Full Text] [Related]
3. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
[TBL] [Abstract][Full Text] [Related]
4. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
5. Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey.
Krempf M; Simpson RJ; Ramey DR; Brudi P; Giezek H; Tomassini JE; Lee R; Farnier M
Lipids Health Dis; 2015 May; 14():45. PubMed ID: 25985907
[TBL] [Abstract][Full Text] [Related]
6. Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C.
Katzmann JL; Sorio-Vilela F; Dornstauder E; Fraas U; Smieszek T; Zappacosta S; Laufs U
Clin Res Cardiol; 2022 Mar; 111(3):243-252. PubMed ID: 32949286
[TBL] [Abstract][Full Text] [Related]
7. Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia.
Toth PP; Catapano AL; Farnier M; Foody J; Tomassini JE; Jensen E; Polis AB; Hanson ME; Musliner TA; Tershakovec AM
Am J Cardiol; 2016 Dec; 118(12):1812-1820. PubMed ID: 27756478
[TBL] [Abstract][Full Text] [Related]
8. Does the addition of ezetimibe to statins reduce cardiovascular risk?
Araya FI; Grassi B
Medwave; 2016 Dec; 16(Suppl5):e6632. PubMed ID: 27922588
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the efficacy and safety of atorvastatin + ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia.
Ma YB; Chan P; Zhang Y; Tomlinson B; Liu Z
Expert Opin Pharmacother; 2019 Jun; 20(8):917-928. PubMed ID: 30908086
[TBL] [Abstract][Full Text] [Related]
11. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
Lancellotti P; Pierard LA; Scheen AJ
Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
[TBL] [Abstract][Full Text] [Related]
12. Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study.
de Lusignan S; Belsey J; Hague N; Dhoul N; van Vlymen J
J Public Health (Oxf); 2006 Dec; 28(4):361-9. PubMed ID: 17038329
[TBL] [Abstract][Full Text] [Related]
13. Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012.
Gu Q; Paulose-Ram R; Burt VL; Kit BK
NCHS Data Brief; 2014 Dec; (177):1-8. PubMed ID: 25536410
[TBL] [Abstract][Full Text] [Related]
14. Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study.
Miyoshi T; Nakamura K; Doi M; Ito H
Am J Cardiovasc Drugs; 2015 Jun; 15(3):213-9. PubMed ID: 25896669
[TBL] [Abstract][Full Text] [Related]
15. [Update of planning tables of cholesterol-lowering therapy orientated to achieve LDL therapeutic targets].
Masana L; Plana N
Clin Investig Arterioscler; 2015; 27(3):138-43. PubMed ID: 25865752
[TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study.
Punekar RS; Fox KM; Paoli CJ; Richhariya A; Cziraky MJ; Gandra SR; Toth PP
Curr Med Res Opin; 2017 May; 33(5):869-876. PubMed ID: 28276256
[TBL] [Abstract][Full Text] [Related]
17. Patient characteristics, treatment patterns, and adherence to lipid-lowering therapies following an acute coronary syndrome.
Bruckert E; Desamericq G; Khachatryan A; Ngo P; Gusto G; Sorio-Vilela F
Rev Cardiovasc Med; 2020 Dec; 21(4):643-650. PubMed ID: 33388010
[TBL] [Abstract][Full Text] [Related]
18. Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using data registries.
Ara R; Pandor A; Tumur I; Paisley S; Duenas A; Williams R; Wilkinson A; Durrington P; Chilcott J
Clin Ther; 2008 Aug; 30(8):1508-23. PubMed ID: 18803993
[TBL] [Abstract][Full Text] [Related]
19. Safety of coadministration of ezetimibe and statins in patients with hypercholesterolaemia: a meta-analysis.
Luo L; Yuan X; Huang W; Ren F; Zhu H; Zheng Y; Tang L
Intern Med J; 2015 May; 45(5):546-57. PubMed ID: 25644680
[TBL] [Abstract][Full Text] [Related]
20. Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications.
Leporowski A; Godman B; Kurdi A; MacBride-Stewart S; Ryan M; Hurding S; Do Nascimento RC; Bennie M; Morton A
Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):655-666. PubMed ID: 30014725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
